慢性乙型肝炎相关肝纤维化中医诊疗进展与思考  

Advances and thoughts in traditional Chinese medicine diagnosis and treatment of chronic hepatitis B-related liver fibrosis

作　　者：萧焕明[1,2] 施梅姐 谢玉宝[1,2] 池晓玲 XIAO Huanming;SHI Meijie;XIE Yubao;CHI Xiaoling(Guangdong Provincial Hospital of Chinese Medicine,Guangzhou 510120,China;The Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510120,China)

机构地区：[1]广东省中医院肝病科,广州510120 [2]广州中医药大学第二附属医院肝病科,广州510120

出　　处：《临床肝胆病杂志》2023年第2期260-266,共7页Journal of Clinical Hepatology

基　　金：国家“十三五”重大传染病专项课题(2018ZX10725506-003,2018ZX10725505-004);广东省中医药局面上项目(20225022);广东省中医院院内专项(YN10101903,YN2016XP03,YN2022DB04);池晓玲国家中医药管理局名老中医药专家传承工作室项目(国中医药人教函[2022]75号);第五批全国中医临床优秀人才研修项目(国中医药人教函[2022]1号)。

摘　　要：肝纤维化是慢性乙型肝炎发展至肝硬化、肝癌的必经中间过程。近年来,中医药防治慢性乙型肝炎肝纤维化的研究取得突破性进展。以提高临床疗效为目的,多学科联合开展产学研研究,阐释慢性乙型肝炎肝纤维化中医证候生物学基础、建立与研发中医特色无创诊断模型,优化中医/中西医结合治疗方案并阐释中医治疗的科学内涵能够帮助中医药防治肝纤维化走向国际。Liver fibrosis is a necessary intermediate process from the progression of chronic hepatitis B to liver cirrhosis and liver cancer.In recent years,breakthroughs have been made in the research on traditional Chinese medicine(TCM) for the prevention and treatment of chronic hepatitis B liver fibrosis.For the purpose of improving clinical outcome,multidisciplinary industry-university-research studies are conducted to explain the biological basis of TCM syndromes of chronic hepatitis B liver fibrosis,and establishment and development of a non-invasive diagnostic model with TCM characteristics,optimization of TCM/integrated traditional Chinese and Western medicine treatment regimens,and elaboration on the scientific connotation of TCM treatment can help TCM for the prevention and treatment of liver fibrosis to enter the global world.

关 键 词：乙型肝炎 慢性 肝纤维化 诊断 治疗学 医学 中国传统 

分 类 号：R259[医药卫生—中西医结合]